institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Lyell Immunopharma (LYEL) Stock Soars Following Private Placement Announcement

Shares of Lyell Immunopharma Inc. (NASDAQ: LYEL) surged by 20% on Friday morning, driven by news of a substantial private placement financing deal worth up to $100 million, aimed at advancing its lead CAR T-cell therapy candidate, LYL314. The company disclosed that it has entered into agreements with institutional investors for the initial closing of approximately $50 million in common stock at a price of $13.32 per share, expected to finalize o…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

financialbuzz.com broke the news in on Friday, July 25, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.